BlueSky Immunotherapies GmbH
4 clinical trials · Sponsor
◉ Watch BlueSky Immunotherapies GmbH
| Record | Firm | Date |
|---|---|---|
| Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal Cancer (NCT06589609) | BlueSky Immunotherapies GmbH | 2024-08-23 |
| Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women (NCT05829629) | BlueSky Immunotherapies GmbH | 2023-09-12 |
| BS-FU01 Follow-Up Study of FluBHPVE6E7 Study Subjects (NCT04528407) | BlueSky Immunotherapies GmbH | 2021-04-09 |
| Study of FluBHPVE6E7 in HPV-16 Infected Women (NCT04490512) | BlueSky Immunotherapies GmbH | 2020-12-09 |
Track BlueSky Immunotherapies GmbH automatically
Every clearance here is in the API, with alerts when new ones post.